Teladoc Health Inc. (NYSE:TDOC) finished Thursday with an addition of $0.92 to close at $23.85, an upside of 4.01 percent. An average of 5,286,660 shares of common stock have been traded in the last five days. There was a fall of -$2.62 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 4,016,020 shares traded, while the 50-day average volume stands at 4,619,704.
TDOC stock has decreased by -12.09% in the last month. The company shares reached their 1-month lowest point of $22.35 on 12/28/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $22.35 and a high of $96.64 in 52 weeks. It has reached a new high 2 times so far this year and lost -74.03% or -$67.97 in price. In spite of this, the price is down -75.32% from the 52-week high.
TDOC stock investors should be aware that Teladoc Health Inc. (TDOC) stock had its last reported insider trading activity 11 days ago on Dec 19. In this transaction, the insider spent $26,930. CHIEF INNOVATION OFFICER, Jensen Claus Torp, disposed of 1,783 shares at a price of $28.86 on Dec 01. The insider now owns more than $51,457 worth of shares. Prior to that, CHIEF PEOPLE OFFICER Geshuri Arnnon went on to Sale 2,398 shares at $27.35 each on Nov 28. An amount of $65,595 was transacted.
Teladoc Health Inc. (TDOC) stock’s beta is 0.97. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.71, the price-to-book (PB) ratio at 0.64, and the price-to-cash flow ratio at 20.50.
The quick ratio of Teladoc Health Inc. for the three months ended September 29 was 3.00, and the current ratio was 3.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.25 and a total debt to equity ratio of 0.26 for the quarter ending September 29. Its gross profit as reported stood at $1.38 billion compared to revenue of $2.03 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Teladoc Health Inc.’s return on assets was -87.60%.
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$73.48 million in the quarter, while revenues of -$3.1 billion were shrunk -82.12%. The analyst consensus anticipated Teladoc Health Inc.’s latest quarter earnings to come in at -$0.57 per share, but it turned out to be -$0.45, a 21.10% surprise. For the quarter, EBITDA amounted to -$5.46 million. Shareholders own equity worth $161.93 million.
From a technical analysis perspective, let’s take a brief look at Teladoc Health Inc. (TDOC) price momentum. RSI 9-day as of the close on 29 December was 36.10%, suggesting the stock is Neutral, with historical volatility in this time frame at 57.55%.
As of today, TDOC’s price is $23.47 -9.90% or -$2.62 from its 5-day moving average. TDOC is currently trading -16.35% lower than its 20-day SMA and -38.52% lower than its 100-day SMA. However, the stock’s current price level is -6.29% below the SMA50 and -56.26% below the SMA200.
The stochastic %K and %D were 9.00% and 5.31%, respectively, and the average true range (ATR) was 1.39. With the 14-day stochastic at 18.80% and the average true range at 1.47, the RSI (14) stands at 38.31%. The stock has reached -1.52 on the 9-day MACD Oscillator while the 14-day reading was at -2.60.
Guggenheim upgraded Teladoc Health Inc. (NYSE: TDOC) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Sell. The consensus rating for Teladoc Health Inc. (TDOC) among analysts is Hold. According to current brokerage recommendations, 0 brokerage firms advise that investors sell TDOC, while 25 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is TDOC’s price target for the next 12 months?
Analysts predict a range of price targets between $24.00 and $45.00, with a median target of $32.00. Taking a look at these predictions, the average price target given by analysts for Teladoc Health Inc. (TDOC) stock is $32.18.